Trials / Withdrawn
WithdrawnNCT03284047
Botox for Gummy Smile
Evaluation of Different Doses of Botulinum Toxin Type A for the Treatment of Gummy Smile
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a two part study to measure and observe the efficacy of botulinum toxin A for the treatment of gummy smiles. Part A will randomly compare three different doses of botulinum toxin type A (abobotulinumtoxin A) for the treatment of upper anterior gummy smile with larger gingival exposure (\> 4 mm). Part B will assign one of two doses of botulinum toxin type A for participants with smaller gingival exposure (\< 4 mm). Follow-up visits with photography will occur 4 and 12 weeks after their treatment. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. This study is a pilot study designed to determine feasibility of this procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin type A | Participants will be randomized to one of three botulinum toxin type A doses. |
Timeline
- Start date
- 2019-04-24
- Primary completion
- 2019-04-24
- Completion
- 2019-04-24
- First posted
- 2017-09-15
- Last updated
- 2021-12-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03284047. Inclusion in this directory is not an endorsement.